Log In
Print
BCIQ
Print
Print this Print this
 

DP-VPA

Also known as: SPD 421

  Manage Alerts
Collapse Summary General Information
Company D-Pharm Ltd.
DescriptionPhospholipid derivative of valproic acid formulated with Regulated Activation of Prodrugs (D-RAP) technology
Molecular Target Histone deacetylase (HDAC)
Mechanism of ActionHistone deacetylase (HDAC) inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today